Problems relating to the laboratory diagnosis of factor XIII deficiency: A UK NEQAS study

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 12, 2003, Pages 2603-2608

  Jennings, I ^a   Kitchen, S ^a   Woods, T A L ^a   Preston, F E ^a  

^a UK NEQAS Blood Coagulation   (United Kingdom)

Author keywords

External quality assessment; Factor XIII; Screening tests

Indexed keywords

ACETIC ACID; DIAGNOSTIC AGENT; THROMBIN;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; DIAGNOSIS, MEASUREMENT AND ANALYSIS; FAMILY HEALTH; HEALTH CARE QUALITY; HUMAN; MASS SCREENING; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED KINGDOM;

ACETIC ACID; BLOOD COAGULATION TESTS; FACTOR XIII DEFICIENCY; FAMILY HEALTH; GREAT BRITAIN; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MASS SCREENING; QUALITY ASSURANCE, HEALTH CARE; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBIN;

EID: 1542440244     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00469.x     Document Type: Article

References (17)

1. Board PG, Losowsky MS, Miloszewski KJA. Factor XIII: inherited and acquired deficiency. Blood Rev 1993; 7: 229-42.
2. Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilising factor defi-ciency. Thromb Diath Haemorr 1960; 5: 179-86.
3. Egbring R, Kroniger A, Seitz R. Factor XIII deficiency. Pathogenic mechanisms and clinical significance. Semin Thromb Haemost 1996; 22: 419-26.
4. Losowsky MS, Miloszowsky KJA. Factor XIII. Br J Haematol 1977; 37: 1-5.
5. Chanarin I. Laboratory Haematology. An Account of Laboratory Tech-niques. Edinburgh: Churchill Livingstone, 1989.
6. Kitchen S, Walker ID, Woods TAL, Preston FE, on behalf of the Steering Committee of the UK NEQAS in Blood Coagulation. Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Thromb Haemost 1994; 72: 426-9.
7. Seitz R, Duckert F, Lopaciuk MD, Muszbek L, Rodeghiero F, Seligsohn U. ETRO working party on factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Semin Thromb Haemost 1996; 22: 415-8.
8. Kamitsuji H, Tank K, Yasui M, Taniguchi A, Taira K, Tsukada S, Iida Y, Kanki H, Fukui H. Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schonlein purpura. Effi-cacy of factor XIII substitution. Eur J Pediatr 1987; 146: 519-23.
9. Biland L, Duckert F, Prisender S, Nyman D. Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen. Thromb Haemost 1978; 39: 646-56.
10. Lorenz R, Olbert P, Born P. Factor XIII in chronic inflammatory bowel disease. Semin Thromb Haemost 1996; 22: 451-5.
11. Murdock PJ, Owens DL, Chitolie A, Hutton RA, Lee CA. Development and evaluation of ELISAs for factor XIIIA and XIIIB subunits in plasma. Thromb Res 1992; 67: 73-9.
12. Dvilansky A, Britten AFH, Loewy AG. Factor XIII by an isotope method. Br J Haematol 1970; 18: 399-410.
13. Fickensher K, Aab A, Stuber WA. Photometric assay for blood coagula-tion factor XIII. Thromb Haemost 1991; 65: 535-40.
14. Wilmer M, Rudin K, Kolde H, Poetzsch B, Lenz W, Moessmer G, Meili E, Egbring R, Gempeler-Messina P, Gempeler M, Bastian S, Kohler H. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency. Throm Res 2001; 102: 81-91.
15. Francis JL. The detection and measurement of Factor XIII activity: a review. Med Lab Sci 1980; 37: 137-47.
16. Jakobsen E, Godal HC. Simple, semiquantitative test for partial factor XIII deficiency. Scand J Haemat 1974; 12: 366-8.
17. Dacie JV, Lewis SM. Practical Haematology, 6th edn. Edinburgh: Churchill Livingstone, 1984